Thursday 11 January 2018

Smart Healthcare Market Is Expected To Grow Due To Growing Implementation Of Inventory Management Systems By 2022 : Grand View Research, Inc.

Global smart healthcare market is expected to reach USD 225.54 Billion by 2022, according to a new study by Grand View Research, Inc. Rapid technological advancements in healthcare IT is expected to remain a key driving factor of the global smart healthcare market over the forecast period. Growing implementation of inventory management systems such as RFID KanBan and RFID smart cabinets aimed at curbing inventory costs and ensure appropriate logistics management is expected to boost the growth of the smart healthcare market. Development of smart syringes, smart pills and smart bandages which enable remote monitoring of patients, help in diagnosing gastrointestinal diseases and infection spread minimization and remote monitoring of healing processes is expected to strengthen the platform for future market growth. On the other hand, high capital investments and poor awareness levels among consumers are some challenges faced by manufacturers.
mHealth is expected to register the fastest growth of over 40.0% over the forecast period.  Key factors likely to drive segment growth include rapidly increasing incidence rates of chronic diseases, increasing smart phone penetration rates and heightening need to ensure improved healthcare outcomes.
Further key findings from the study suggest:
·         Electronic health record (EHR) emerged as the largest product segment in terms of revenue and was estimated at over USD 19.50 billion in 2014. Implementation of the American Recovery and Reinvestment Act (ARRA) and HITECH Act is expected to make significant contributions towards segment growth. Key feature of HITECH Act includes the provision of USD 64,000 per year to healthcare practitioners adopting EHR systems.
·         North America was the largest smart healthcare regional market in 2014. Presence of favorable government initiatives in the form of HITECH Act providing allowances to healthcare practitioners is one of the major factors expected to drive regional market growth. Presence of sophisticated IT infrastructure enabling easy implementation of advanced healthcare facilities is also expected to boost market growth over the forecast period.
·         Asia Pacific is expected to grow at a considerable pace over the forecast period owing to growing penetration of advanced healthcare facilities and rapidly evolving mobile & IT infrastructure. Increasing awareness among consumers pertaining to novel healthcare technologies such as telemedicine, mHealth and EHR is expected to further complement regional market growth.
·         Key players operating in the smart healthcare market include Cisco, IBM, Olympus Corp., GE Healthcare, AT&T Inc., Apple Inc., Samsung Electronics, Logi-Tag, Wurth Group, AirStrip Technologies Inc., Allscripts Healthcare Solutions Inc., Pepperl+Fuchs and Given Imaging Inc.
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the smart healthcare market on the basis of product, and region:
Global Smart Healthcare Product Outlook (Revenue, USD Million, 2014 - 2022)
·         RFID KanBan systems
·         RFID smart cabinets
·         Electronic Health Records (EHR)
o    Client-server based
o    Web-based
·         Telemedicine
o    Hardware
o    Connectivity and network
o    Others
·         mHealth
o    Monitoring services
o    Diagnosis services
o    Healthcare systems
o    Others
·         Smart pills
·         Smart syringes
Smart Healthcare  Regional Outlook (Revenue, USD Million, 2014 - 2022)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
o    India
·         MEA
o    South Africa
·         Latin America
o    Brazil
o    Mexico
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-smart-healthcare-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

TPU films market expected to grow due to Increasing use of TPU films by 2020 : Grand View Research, Inc.

The global TPUfilms market is expected to reach USD 724.6 million by 2020, according to a new study by Grand View Research, Inc. Automotive applications dominated the TPU films market, with demand estimated at 11,622.1 tons in 2013. Increasing use of TPU films in automotive applications such as paint protection, scratch protection, anti-chipping and rear bumper protection coupled with growing after sales market is expected to fuel market growth.
Asia Pacific emerged as the largest regional TPU films market, with demand estimated at 16,299 tons in 2013. Growth of automotive industry coupled with increasing application of TPU films in sports goods and construction is expected to drive the market growth over the next six years, at an estimated CAGR of 7.8% from 2014 to 2020. Furthermore, lower TPU film prices in Asia Pacific compared to other regional markets may also complement market growth.
Further key findings from the study suggest:
·         Global TPU films market demand was 46,769.1 tons in 2013 and is expected to reach 68,033.1 tons by 2020, growing at a CAGR of 5.5% from 2014 to 2020.
·         Aerospace is expected to be the fastest growing application segment, at an estimated CAGR of 6.6% from 2014 to 2020.
·         North America and Europe accounted for over 27% and 19% of the total market volume in 2013, respectively. Increasing use of TPU films in automotive and construction applications is expected to drive the market growth in these regions.
·         China and India dominated the TPU films market in Asia Pacific and accounted for over 60% of the market volume in 2013.
·         Japan TPU films demand was estimated at 3,685.4 tons in 2013 and is expected to grow at an estimated CAGR of 4.9% from 2014 to 2020.
·         The global TPU films market is highly fragmented with the top four companies including Bayer Material Science, Huntsman, 3M and Permali Gloucester Limited, accounting for just over 40% of the market in 2013. Other companies in the market include American Polyfilm Inc., PAR Group, Nippon, Lubrizol and Avery Dennison.
Browse more reports of this category by Grand View Research:  https://www.grandviewresearch.com/industry/plastics-polymers-and-resins
Grand View Research has segmented the TPU films market on the basis of application and region:
Global TPU Films Market Application Outlook (Volume, Tons; Revenue, USD Million, 2012 - 2020)
·         Automotive
·          Railway
·         Leisure and sports
·         Energy
·         Building & Construction
·         Furniture
·         Aerospace
·         Others
Global TPU Films Regional Outlook (Volume, Tons; Revenue, USD Million, 2012 - 2020)
·         North America
·         Europe
·         Asia Pacific
·         Japan
·         RoW
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-thermoplastic-polyurethane-tpu-films-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com



Influenza Diagnostics Market Expected To Grow By 2024 Due To Increasing Prevalence Of Chronic Diseases Such As Respiratory, Heart And Blood Disorders : Grand View Research, Inc.

The influenzadiagnostics market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.
Rapid Influenza Diagnostic Tests (RIDTs) accounted for the largest share in 2015. RIDTs are tests that deliver accurate results in approximately 15 minutes. This factor deems them efficient, which has resulted in the lucrative growth of this segment with the fastest CAGR. Reverse transcription polymerase chain reaction (RT-PCR) holds the second highest market share following RIDTs, and this can be attributed to the fact that it provides detailed analytical results, sharper turnaround times, and high throughput.
Hospitals held the highest market share in 2015, but Point-of-Care Testing (POCT) is anticipated to overtake and lead the market in the coming future, owing to the increasing usage of POCT because of its ease of use and short turnaround times.
North America dominates the market, due to a high focus of the government and healthcare bodies to control influenza.
Further Key Findings From the Study Suggest:
·         North America is anticipated to dominate the global influenza diagnostics market. The high adoption rates of in vitro diagnostics and presence of technologically advanced medical devices is expected to drive growth in the region.
·         The Asia Pacific region is anticipated to be the fastest growing region in the study period. This growth is attributed to factors such as increasing initiatives by the countries to counter the incidence of the disease. For instance, CDC reached a cooperative agreement with South-East Asian Region to fund non research-related bilateral influenza as a measure to respond to avian, seasonal, and pandemic influenza.
·         The RIDT segment is expected to grow at a significant rate compared to others and accounts for the largest share in 2015.
·         This market comprises several local as well as global players. Some of the major players of this vertical include Becton, Dickinson and Company, Roche Diagnostics, Alere, Quidel Corporation, and Thermo Fisher Scientific.
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the influenza diagnostics market on the basis of test type, end use, and region:
Test Type Outlook (Revenue, USD Million, 2013 - 2024)
·         RIDTs
·         RT-PCR
·         Cell Culture
·         Others
End-use Outlook (Revenue, USD Million, 2013 - 2024)
·         Hospital
·         Point-of-Care Testing
·         Laboratories
Regional Outlook (Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    India
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa
o    Saudi Arabia
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-influenza-diagnostics-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com


Wednesday 10 January 2018

Hyperbaric Oxygen Therapy Devices Market Expected To Grow Due To Growing Inclination Of Healthcare Professionals By 2025 : Grand View Research, Inc.


The global hyperbaricoxygen therapy devices market is expected to reach USD 3.91 billion by 2025, according to a new report by Grand View Research, Inc. Growing inclination of healthcare professionals toward oxygen therapy, despite a lack of conclusive evidence is one of the key factors expected to drive the market over the coming few years.
Although the off-label usage of HBOT devices in various applications such as cancer and brain injury is controversial, the adoption rate of this technology is surging at a rapid pace. The high commercial availability of HBOT systems is one of the crucial factors that is anticipated to drive the market over the forecast period. However, few medical professionals are still skeptical about the usage of HBOT devices in unapproved applications, which is expected to impede growth. The technological advancements in this field such as portable HBOT system and growing awareness among healthcare professionals regarding the benefits of integrating ICU systems in multiplace HBOT equipment are some of the key contributors that are accountable for robust growth rate.
According to few publications, nearly 30,000 HBOT treatments are done on a daily basis globally. Other than the surging clinical prevalence and rising adoption of hospital setting HBOT systems, there is a considerable growth in popularity and demand for HBOT systems in home settings owing to its easy usage. Increasing private & public investment to expand geographical presence and surging R&D activities are also some of the factors that are anticipated to boost the demand.
Further Key Findings From the Report Suggest:
·         The global hyperbaric oxygen therapy (HBOT) market size was estimated at USD 2,210.5 million in 2016 and is expected to grow at a CAGR of 6.5% from 2017 to 2025
·         Monoplace HBOT Devices segment emerged as the largest product segment in 2016 and is estimated to generate revenue over USD 3,008.8 million by 2025
·         Other applications such as acute carbon monoxide poisoning, chemotherapy-induced hemorrhagic cystitis, and cyanide poisoning generated revenue of USD 229.1 million in 2016 and is anticipated to witness fastest growth over the next 8 years
·         The Asia Pacific region is anticipated to witness lucrative growth over the next decade owing to various developments in healthcare infrastructure and technological advancements in the medical device industry across major emerging economies. It is expected to grow at a CAGR of 7.1% over the forecast period.
·         Some of the key players including Fink Engineering; HAUX-LIFE-SUPPORT; ETC Hyperbaric Chambers (Environmental Tectonics Corporation); Gulf Coast Hyperbarics, Inc.; IHC Hytech B.V. (Royal IHC); HEARMEC; Hyperbaric; Sechrist Industries, Inc.; OxyHeal International; and SOS Group Global Ltd. dominated the global hyperbaric oxygen therapy devices market.
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global hyperbaric oxygen therapy (HBOT) devices market on the basis of product, application, and region:
HBOT Devices Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Monoplace HBOT Devices
·         Multiplace HBOT Devices
·         Topical HBOT Devices
HBOT Devices Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Wound Healing
·         Decompression Sickness
·         Infection Treatment
·         Gas Embolism
·         Others
HBOT Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa
View press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-hyperbaric-oxygen-therapy-hbot-devices-market

About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com